These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction. Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441 [TBL] [Abstract][Full Text] [Related]
15. Impact of Transplant Body Mass Index and Post-Transplant Weight Changes on the Development of Chronic Lung Allograft Dysfunction Phenotypes. Beauchamp-Parent C; Jomphe V; Morisset J; Poirier C; Lands LC; Nasir BS; Ferraro P; Mailhot G Transplant Proc; 2024; 56(6):1420-1428. PubMed ID: 38991901 [TBL] [Abstract][Full Text] [Related]
16. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival. Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624 [TBL] [Abstract][Full Text] [Related]
17. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival. Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181 [TBL] [Abstract][Full Text] [Related]